Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
The Journal of Molecular Diagnostics : JMD|February 17, 2022
Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma with Comprehensive Genomic ProfilingIan M Silverman, Meijuan Li, Karthikeyan Murugesan, et al.The Journal of Molecular Diagnostics : JMD|March 21, 2023
Detection of Biallelic Loss of DNA Repair Genes in Formalin-Fixed, Paraffin-Embedded Tumor Samples Using a Novel Tumor-Only Sequencing PanelDominik Glodzik, Pier Selenica, Ryan A Rogge, et al.Journal of the National Cancer Institute|May 6, 2024
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)Elisa Fontana, Ezra Rosen, Elizabeth K Lee, et al.Cell Metabolism|August 11, 2016
Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal MuscleDavid W Frederick, Emanuele Loro, Ling Liu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
Genomic and epigenomic ctDNA profiling in liquid biopsies from heavily pre-treated patients with DNA damage response-deficient tumorsIan M Silverman, Joseph D Schonoft, Benjamin Herzberg, et al.Molecular Cancer Therapeutics|April 1, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient LeiomyosarcomasMichael S Nakazawa, Ian M Silverman, Victoria Rimkunas, et al.Journal of Neurological Surgery. Part B, Skull Base|November 22, 2019
Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent <i>AKT1 E17K</i> Mutations in Foramen Magnum MeningiomasSally R Williams, Tareq A Juratli, Brandyn A Castro, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2026
Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response (DDR) Aberrations: Preclinical and Phase 1b ResultsEzra Y Rosen, Timothy A Yap, Elisa Fontana, et al.Oncotarget|January 10, 2018
Intratumoral heterogeneity and <i>TERT</i> promoter mutations in progressive/higher-grade meningiomasTareq A Juratli, Christian Thiede, Mara V A Koerner, et al.Nature Medicine|June 5, 2023
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial resultsTimothy A Yap, Elisa Fontana, Elizabeth K Lee, et al.Pageof 4